Novel drug reverses paralysis in mice with multiple sclerosis
Researchers from the University of Utah Health (UT, USA) have developed a novel drug for the selective treatment of autoimmune diseases, which has been shown to suppress diabetes and treat multiple sclerosis in mouse models.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>